InMode (INMD) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.14% |
| Dec 31, 2025 | -7.33% |
| Sep 30, 2025 | 1.64% |
| Jun 30, 2025 | 71.40% |
| Mar 31, 2025 | -56.71% |
| Dec 31, 2024 | -4.72% |
| Sep 30, 2024 | -19.04% |
| Jun 30, 2024 | 74.42% |
| Mar 31, 2024 | -60.58% |
| Dec 31, 2023 | 47.59% |
| Sep 30, 2023 | -21.80% |
| Jun 30, 2023 | 151.03% |
| Mar 31, 2023 | -63.06% |
| Dec 31, 2022 | 25.36% |
| Sep 30, 2022 | -2.96% |
| Jun 30, 2022 | 47.49% |
| Mar 31, 2022 | -39.78% |
| Dec 31, 2021 | 4.79% |
| Sep 30, 2021 | 7.96% |
| Jun 30, 2021 | 88.78% |
| Mar 31, 2021 | -40.45% |
| Dec 31, 2020 | 37.73% |
| Sep 30, 2020 | 2,180.51% |
| Jun 30, 2020 | -78.37% |
| Mar 31, 2020 | -77.68% |
| Dec 31, 2019 | 102.88% |
| Sep 30, 2019 | -26.95% |
| Jun 30, 2019 | 567.67% |
| Mar 31, 2019 | -70.71% |
| Dec 31, 2018 | 30.93% |
| Sep 30, 2018 | -43.56% |